The case will decide whether courts can rely on a parliamentary standing committee report during judicial proceedings.
Ms Kalpana Mehta filed a Public Interest Litigation (PIL) in 2012 for de-licensing two cervical vaccines due to alleged irregularities in clinical trials. There were reports of people dying due to the after-effect of these two vaccines – Gardasil and Cervarix, manufactured by Merck Sharp and Dohme and GlaxoSmithKline Plc.
The 81st Parliamentary Standing Committee (PSR) on Health and Family Welfare in their December 2014 Report had found grave irregularities in clinical trials for these vaccines. The report also recorded irregularities in obtaining consent from the clinical trial subjects and the deviation from various established protocols.
When the Standing Committee Report was brought to the notice of the Court, a question arose whether the Court can rely on a report of the Parliamentary Standing Committee and issue directions under Article 32. The drug companies argued that using PSRs to issue judicial direction violates freedom of speech and expression of the Members of Parliament under Article 105. It also violates Article 121 which prohibits the court from inquiring into parliamentary proceedings.
On the question of using PSRs as an external aid of interpretation to issue judicial directions, a 2 judge-bench comprising Justices Dipak Misra and Rohinton Nariman observed that the issue involves a substantial question of law relating to constitutional interpretation. The matter was referred to a Constitution Bench.
Arguments have concluded, and the judgment has been reserved.
Whether a Parliamentary Standing Committee Report can be looked at for the purpose of reference. Does the concept of parliamentary privilege under Article 105 and Article 121 restrict the reliance on PSC Reports?
Whether the Supreme Court can refer to and rely on a report of the Parliamentary Standing Committee under Article 32 or Article 136 of the Constitution.